New study tests antibiotic beads vs discs to save breast implants
NCT ID NCT07339215
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of antibiotic carriers placed during tissue expander breast reconstruction to lower infection risk. About 100 women will receive either absorbable antibiotic beads or a non-absorbable disc, both releasing vancomycin and tobramycin. Researchers will measure antibiotic levels in breast fluid and track infections and complications for 90 days. The goal is to find which method better prevents infections that can lead to pain, extra surgeries, or loss of the reconstruction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- antibiotic-loaded calcium sulfate beads and polymethylmethacrylate antibiotic disc (both containing vancomycin and tobramycin)
- What this could lead to
- If one method works better, it could reduce infections, pain, and the need for extra surgeries after breast reconstruction.
- What could go wrong
- This is a small, early-stage study with only 100 patients. It compares two existing methods, so neither may prove clearly better. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TISSUE EXPANDER BASED BREAST RECONSTRUCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UC Davis Medical Center
Sacramento, California, 95817, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.